F2-Isoprostane level is associated with the angiotensin II type 1 receptor -153A/G gene polymorphism

Free Radical Biology and Medicine

Volumn 38, Issue 5, 2005, Pages 583-588

  Ormezzano, Olivier ^a   Cracowski, Jean Luc ^b   Mallion, Jean Michel ^a   Poirier, Odette ^c   Bessard, Janine ^b   Briançon, Serge ^d   François, Patrice ^a   Baguet, Jean Philippe ^a  

^a HÔPITAL MICHALLON   (France)

^b UNIV GRENOBLE ALPES   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Angiotensin II type 1 receptor; Free radicals; Genetics; Lipid peroxidation; Oxidative stress; Renin angiotensin system; Single nucleotide polymorphism

Indexed keywords

ALDOSTERONE SYNTHASE; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; ISOPROSTANE DERIVATIVE; ANGIOTENSIN II;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ESSENTIAL HYPERTENSION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MALE; MULTIVARIATE ANALYSIS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC POLYMORPHISM; GENETICS; HYPERTENSION; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; ANGIOTENSIN II; F2-ISOPROSTANES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 15744370947     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.11.028     Document Type: Article

References (41)

1. D.S. Jacoby, and D.J. Rader Renin-angiotensin system and atherothrombotic disease: from genes to treatment Arch. Intern. Med. 163 2003 1155 1164
2. N.J. Samani, S.R. Thompson, L. O'Toole, K. Channer, and K.L. Woods A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction Circulation 94 1996 708 712
3. T. Katsuya, G. Koike, T.W. Yee, N. Sharpe, R. Jackson, R. Norton, M. Horiuchi, R.E. Pratt, V.J. Dzau, and S. MacMahon Association of angiotensin gene T235 variant with increased risk of coronary heart disease Lancet 345 1995 1600 1603
4. X. Jeunemaitre, F. Ledru, S. Battaglia, M.T. Guillanneuf, D. Courbon, C. Dumont, O. Darmon, L. Guize, J.L. Guermonprez, B. Diebold, and P. Ducimetiere Genetic polymorphisms of the renin-angiotensin system and angiographic extent and severity of coronary artery disease: the CORGENE study Hum. Genet. 99 1997 66 73
5. J.C. Rodriguez-Perez, F. Rodriguez-Esparragon, O. Hernandez-Perera, A. Anabitarte, A. Losada, A. Medina, E. Hernandez, D. Fiuza, O. Avalos, C. Yunis, and C.M. Ferrario Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study J. Am. Coll. Cardiol. 37 2001 1536 1542
6. J.R. Ortlepp, J. Metrikat, V. Mevissen, F. Schmitz, M. Albrecht, P. Maya-Pelzer, P. Hanrath, K. Zerres, and R. Hoffmann Relation between the angiotensinogen (AGT) M235T gene polymorphism and blood pressure in a large, homogeneous study population J. Hum. Hypertens 17 2003 555 559
7. J.J. Rogus, D. Moczulski, M.B. Freire, Y. Yang, J.H. Warram, and A.S. Krolewski Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study Hypertension 31 1998 627 631
8. A. Benetos, S. Gautier, S. Ricard, J. Topouchian, R. Asmar, O. Poirier, E. Larosa, L. Guize, M. Safar, F. Soubrier, and F. Cambien Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients Circulation 94 1996 698 703
9. Y. Nakauchi, T. Suehiro, M. Yamamoto, N. Yasuoka, K. Arii, Y. Kumon, N. Hamashige, and K. Hashimoto Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk factors for coronary heart disease Atherosclerosis 125 1996 161 169
10. C. Amant, M. Hamon, C. Bauters, F. Richard, N. Helbecque, E.P. McFadden, X. Escudero, J.M. Lablanche, P. Amouyel, and M.E. Bertrand The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction J. Am. Coll. Cardiol. 29 1997 486 490
11. J.F. Reckelhoff, H. Zhang, K. Srivastava, and L.J. Roberts Subpressor doses of angiotensin II increase plasma F(2)-isoprostanes in rats Hypertension 35 2000 476 479
12. M.C. Ortiz, E. Sanabria, M.C. Manriquez, J.C. Romero, and L.A. Juncos Role of endothelin and isoprostanes in slow pressor responses to angiotensin II Hypertension 37 2001 505 510
13. J.A. Haas, J.D. Krier, R.J. Bolterman, L.A. Juncos, and J.C. Romero Low-dose angiotensin II increases free isoprostane levels in plasma Hypertension 34 1999 983 986
14. T. Aizawa, N. Ishizaka, S. Usui, N. Ohashi, M. Ohno, and R. Nagai Angiotensin II and catecholamines increase plasma levels of 8-epi-prostaglandin F(2alpha) with different pressor dependencies in rats Hypertension 39 2002 149 154
15. 2-isoprostanes as an index of oxidative stress in vivo Free Radic. Biol. Med. 28 2000 505 513
16. P. Minuz, P. Patrignani, S. Gaino, M. Degan, L. Menapace, R. Tommasoli, F. Seta, M.L. Capone, S. Tacconelli, S. Palatresi, C. Bencini, C. Del Vecchio, G. Mansueto, E. Arosio, C.L. Santonastaso, A. Lechi, A. Morganti, and C. Patrono Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease Circulation 106 2002 2800 2805
17. J.L. Cracowski, J.P. Baguet, O. Ormezzano, J. Bessard, F. Stanke-Labesque, G. Bessard, and J.M. Mallion Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension Hypertension 4 2003 286 288
18. N.C. Ward, J.M. Hodgson, I.B. Puddey, T.A. Mori, L.J. Beilin, and K.D. Croft Oxidative stress in human hypertension: association with antihypertensive treatment, gender, nutrition, and lifestyle Free Radic. Biol. Med. 36 2004 226 232
19. J.P. Baguet, J.M. Mallion, A. Moreau-Gaudry, M. Noirclerc, M. Peoc'h, and J.P. Siche Relationships between cardiovascular remodelling and the pulse pressure in never treated hypertension J. Hum. Hypertens 14 2000 23 30
20. J.P. Baguet, A. Moreau-Gaudry, J.P. Siche, S. Douchin, F. Tremel, and J.M. Mallion Carotid remodeling in essential hypertension: role of blood pressure, indexed parameters, and association with cardiac mass and aortic stiffness Clin. Exp. Hypertens 22 2000 717 729
21. J. Bessard, J.L. Cracowski, F. Stanke-Labesque, and G. Bessard Determination of isoprostaglandin F2a type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay J. Chromatogr. B 754 2001 333 343
22. F. Cambien, O. Poirier, V. Nicaud, S.M. Herrmann, C. Mallet, S. Ricard, I. Behague, V. Hallet, H. Blanc, V. Loukaci, J. Thillet, A. Evans, J.B. Ruidavets, D. Arveiler, G. Luc, and L. Tiret Sequence diversity in 36 candidate genes for cardiovascular disorder Am. J. Hum. Genet. 65 1999 183 191
23. J.L. Cracowski, T. Durand, and G. Bessard Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications Trends Pharmacol. Sci. 23 2002 360 366
24. H. Mollnau, M. Wendt, K. Szocs, B. Lassegue, E. Schulz, M. Oelze, H. Li, M. Bodenschatz, M. August, A.L. Kleschyov, N. Tsilimingas, U. Walter, U. Forstermann, T. Meinertz, K. Griendling, and T. Munzel Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling Circ. Res. 90 2002 E58 E65
25. G. Nickenig, and D.G. Harrison The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: part I: oxidative stress and atherogenesis Circulation 105 2002 393 396
26. G. Nickenig, and D.G. Harrison The AT(1)-type angiotensin receptor in oxidative stress and atherogenesis: Part II: AT(1) receptor regulation Circulation 105 2002 530 536
27. E.L. Schiffrin, and R.M. Touyz Multiple actions of angiotensin II in hypertension: benefits of AT1 receptor blockade J. Am. Coll. Cardiol. 42 2003 911 913
28. K.K. Koh, J.Y. Ahn, S.H. Han, D.S. Kim, D.K. Jin, H.S. Kim, M.S. Shin, T.H. Ahn, I.S. Choi, and E.K. Shin Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients J. Am. Coll. Cardiol. 42 2003 905 910
29. L.O. Lerman, K.A. Nath, M. Rodriguez-Porcel, J.D. Krier, R.S. Schwartz, C. Napoli, and J.C. Romero Increased oxidative stress in experimental renovascular hypertension Hypertension. 37 2001 541 546
30. S. Wassmann, S. Hilgers, U. Laufs, M. Bohm, and G. Nickenig Angiotensin II type 1 receptor antagonism improves hypercholesterolemia-associated endothelial dysfunction Arterioscler. Thromb. Vasc. Biol. 22 2002 1208 1212
31. J. Erdmann, K. Riedel, K. Rohde, I. Folgmann, T. Wienker, E. Fleck, and V. Regitz-Zagrosek Characterization of polymorphisms in the promoter of the human angiotensin II subtype 1 (AT1) receptor gene Ann. Hum. Genet. 63 1999 369 374
32. W. Jin, Y. Liu, H.H. Sheng, L. Jin, Y.Y. Shen, Q. Hua, L. Lu, J.D. Yu, and W. Huang Single nucleotide polymorphisms in promoter of angiotensin II type 1 receptor gene associated with essential hypertension and coronary heart disease in Chinese population Acta Pharmacol. Sin. 24 2003 1083 1088
33. O. Poirier, J.L. Georges, S. Ricard, D. Arveiler, J.B. Ruidavets, G. Luc, A. Evans, F. Cambien, and L. Tiret New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde J. Hypertens. 16 1998 1443 1447
34. M. Plumb, J. Frampton, H. Wainwright, M. Walker, K. Macleod, G. Goodwin, and P. Harrison GATAAG; a cis-control region binding an erythroid-specific nuclear factor with a role in globin and non-globin gene expression Nucleic Acids Res. 17 1989 73 92
35. D. Harrison, K.K. Griendling, U. Landmesser, B. Hornig, and H. Drexler Role of oxidative stress in atherosclerosis Am. J. Cardiol. 91 2003 7A 11A
36. J.L. Witztum, and D. Steinberg The oxidative modification hypothesis of atherosclerosis: does it hold for humans? Trends Cardiovasc. Med. 11 2001 93 102
37. K. Juul, A. Tybjaerg-Hansen, S. Marklund, N.H.H. Heegaard, R. Steffensen, H. Sillesen, G. Jensen, and B.G. Nordestgaard Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City Heart Study Circulation 109 2004 59 65
38. Y. Tabara, K. Kohara, J. Nakura, and T. Miki Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system J. Hum. Genet. 46 2001 278 284
39. A.J. Marian, F. Safavi, L. Ferlic, J.K. Dunn, A.M. Gotto, and C.M. Ballantyne Interactions between angiotensin-I-converting enzyme insertion/deletion polymorphism and response of plasma lipids and coronary atherosclerosis to treatment with fluvastatin: the lipoprotein and coronary atherosclerosis study J. Am. Coll. Cardiol. 35 2000 89 95
40. X. Girerd, O. Hanon, J.J. Mourad, P. Boutouyrie, S. Laurent, and X. Jeunemaitre Lack of association between renin-angiotensin system, gene polymorphisms, and wall thickness of the radial and carotid arteries Hypertension. 32 1998 579 583
41. D.K. Arnett, I.B. Borecki, E.H. Ludwig, J.S. Pankow, R. Myers, G. Evans, A.R. Folsom, G. Heiss, and M. Higgins Angiotensinogen and angiotensin-converting enzyme genotypes and carotid atherosclerosis: the atherosclerosis risk in communities and the NHLBI family heart studies Atherosclerosis 138 1998 111 116